Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2012:2012:626417.
doi: 10.1155/2012/626417. Epub 2012 Jun 15.

Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis

Affiliations

Native and Complexed IGF-1: Biodistribution and Pharmacokinetics in Infantile Neuronal Ceroid Lipofuscinosis

Tuulia Huhtala et al. J Drug Deliv. 2012.

Abstract

Infantile neuronal ceroid lipofuscinosis (INCL) is a severe neurodegenerative disorder of childhood characterized by selective death of cortical neurons. Insulin-like growth factor 1 (IGF-1) is important in embryonic development and is considered as a potential therapeutic agent for several disorders of peripheral and central nervous systems. In circulation IGF-1 is mainly bound to its carrier protein IGFBP-3. As a therapeutic agent IGF-1 has shown to be more active as free than complexed form. However, this may cause side effects during the prolonged treatment. In addition to IGFBP-3 the bioavailability of IGF-1 can be modulated by using mesoporous silicon nanoparticles (NPs) which are optimal carriers for sustained release of unstable peptide hormones like IGF-1. In this study we compared biodistribution, pharmacokinetics, and bioavailability of radiolabeled free IGF-1, IGF-1/IGFBP-3, and IGF-1/NP complexes in a Cln1-/- knockout mouse model. IGF-1/NP was mainly accumulated in liver and spleen in all studied time points, whereas minor and more constant amounts were measured in other organs compared to free IGF-1 or IGF-1/IGFBP-3. Also concentration of IGF-1/NP in blood was relatively high and stable during studied time points suggesting continuous release of IGF-1 from the particles.

PubMed Disclaimer

Figures

Figure 1
Figure 1
In vitro release of 125-I labelled IGF-1 from nanoparticles. 20% of the IGF-1 was burst immediately after mixing with mouse plasma and 50% was released after 20 minutes incubation at 37°C. Only 15% was released between 20 and 240 min time points.
Figure 2
Figure 2
(a) Clearance of unbound and complexed IGF-1 in vivo. (b) Pharmacokinetics of free and complexed IGF-1 in selected organs.

Similar articles

Cited by

References

    1. Santavuori P. Neuronal ceroid-lipofuscinoses in childhood. Brain and Development. 1988;10(2):80–83. - PubMed
    1. Vesa J, Hellsten E, Verkruyse LA, et al. Mutations in the palmitoyl protein thioesterase gene causing infantile neuronal ceroid lipofuscinosis. Nature. 1995;376(6541):584–587. - PubMed
    1. Riikonen R, Vanhanen SL, Tyynelä J, Santavuori P, Turpeinen U. CSF insulin-like growth factor-1 in infantile neuronal ceroid lipofuscinosis. Neurology. 2000;54(9):1828–1832. - PubMed
    1. Jalanko A, Vesa J, Manninen T, et al. Mice with Ppt1 Δex4 mutation replicate the INCL phenotype and show an inflammation-associated loss of interneurons. Neurobiology of Disease. 2005;18(1):226–241. - PubMed
    1. Macauley SL, Wozniak DF, Kielar C, Tan Y, Cooper JD, Sands MS. Cerebellar pathology and motor deficits in the palmitoyl protein thioesterase 1-deficient mouse. Experimental Neurology. 2009;217(1):124–135. - PMC - PubMed